At ENHANC3D GENOMICS we are creating new applications to improve human healthcare. Our disruptive technology profiles 3D genome folding at high resolution for all genes and their enhancers simultaneously, and thus links gene enhancers and non-coding genetic variants to their target genes to unlock their potential for therapeutic discovery. Enhanc3D Genomics is a spinout company from Babraham Institute (Cambridge, UK), founded by academic scientists who are leaders in the fields of regulatory genomics and chromosomal architecture. Enhanc3D Genomics is a privately held company headquartered in Cambridge, UK.